SHPA President Professor Michael Dooley and CEO Helen Dowling have met with the new Minister for Health Sussan Ley , Departmental Secretary Martin Bowles, and representatives from the Department of Health at Parliament House in Canberra to discuss the next Community Pharmacy Agreement.
The Minister announced that negotiations around the next Agreement were to commence and SHPA, along with other stakeholders, was invited to present ideas as part of a broader consultation process.
Topics also included PBS and medicines supply chain.
SHPA focussed its presentation on the need for any funding arrangement to be transparent, consumer oriented and outcome focused, and that there be proper evaluation of the services and allow review of the investment.
“There is the opportunity to learn from other sectors, like hospitals, with respect to the implementation of evidence-based models that can make a difference and lead to better and more cost-effective use of medicines,” says Prof Dooley.
“There needs to be a consumer focus to ensure the right service is delivered at the right time and by the right health professional, including the pharmacist, and in a collaborative or team approach to care, whether that be in an outpatient clinic, GP practice or elsewhere.”
SHPA said the Agreement should not just be about the medication supply chain but importantly the cognitive services that need to be provided to ensure the quality use of medicines should be a key focus.
Other stakeholders at the meeting included representatives from the Consumers Health Forum, AMA, RACGP as well as other pharmacy and medicines industry organisations.
The Minister indicated that SHPA and other stakeholders will be consulted and given the opportunity to have further input into the discussions regarding the CPA.